NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

A new method of halting the spread of cancer has been announced by a team of scientists at the University of California, ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and ...

The amendments will also enable the central drug regulator—Central Drugs Standard Control Organisation (CDSCO)—to optimise ...

"Quantum computing is very important to actually move toward the next generation of intelligence modeling,” said Nagendra ...

Taking medications on time, in the right dose and for the prescribed duration can be challenging for patients, and failure to ...

In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research ...

Dr Darren Ting is awarded a five-year MRC Fellowship to use AI and nanotechnology to develop next generation treatments for ...

Drugmaker Eli Lilly said on Tuesday it is launching an artificial intelligence and machine learning platform that provides ...

Myeloma research faces funding uncertainties, yet collaboration and innovation drive optimism for breakthroughs in treatment ...